Literature DB >> 17464297

Diplopia following cataract surgery: a review of 150 patients.

H Nayak1, J P Kersey, D T Oystreck, R A Cline, C J Lyons.   

Abstract

AIM: To study the motility pattern, underlying mechanism, and management of patients who complained of double vision after cataract surgery.
METHODS: A retrospective case note analysis of 150 patients presenting with diplopia after cataract surgery to an orthoptic clinic over a 70-month period. Information was retrieved from orthoptic, ophthalmological, and operating room records.
RESULTS: A total of 3% of patients presenting to the orthoptic clinic had diplopia after cataract surgery. We grouped these according to the underlying mechanisms which were: (1) decompensating pre-existing strabismus (34%), (2) extraocular muscle restriction/paresis (25%), (3) refractive (8.5%), (4) concurrent onset of systemic disease (5%), (5) central fusion disruption (5%), and (6) monocular diplopia (2.5%). Twenty per cent of the patients could not be categorised with certainty. After infiltrational anaesthesia, extraocular muscle restriction/paresis was the commonest presentation, while decompensation of preexisting strabismus was commonest with topical anaesthesia.For the 150 patients seen, prisms were the commonest form of treatment prescribed (64%) either in isolation or in combination with other treatment, including surgery (19%). Convergence and divergence insufficiency/paresis patterns were also common. A changing motility pattern was noted in some patients who had early documentation, with increasing comitance over time (spread of comitance). Partial resolution made it difficult to clearly identify the underlying mechanism in patients with late documentation.
CONCLUSION: Double vision is a troublesome complication of otherwise successful cataract surgery. The use of topical anaesthesia does not abolish this surgical risk.

Entities:  

Mesh:

Year:  2007        PMID: 17464297     DOI: 10.1038/sj.eye.6702847

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

1.  Unilateral lateral rectus resection for horizontal diplopia in adults with divergence insufficiency.

Authors:  David R Stager; Trevor Black; Joost Felius
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-22       Impact factor: 3.117

2.  Inferior rectus muscle recession as a treatment for vertical diplopia following cataract extraction.

Authors:  A M Schild; J Fricke; A Neugebauer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-22       Impact factor: 3.117

3.  Cataract surgery is not associated with post-operative binocular vision anomalies in age-related cataract patients.

Authors:  Qing-Qing Tan; James S Lewis; Chang-Jun Lan; Xuan Liao; Xiao-Li Tang; Jingyun Wang; Saeed Aljohani; Mitchell M Scheiman
Journal:  Ophthalmic Physiol Opt       Date:  2022-06-12       Impact factor: 3.992

4.  Comitant strabismus: Perspectives, present and future.

Authors:  Darren T Oystreck; Christopher J Lyons
Journal:  Saudi J Ophthalmol       Date:  2012-05-23

5.  Preoperative binocular vision characteristics in the age-related cataract population.

Authors:  Qing-Qing Tan; James S Lewis; Chang-Jun Lan; Xuan Liao; Xiao-Li Tang; Jingyun Wang; Mitchell M Scheiman
Journal:  BMC Ophthalmol       Date:  2022-04-27       Impact factor: 2.086

6.  Cataract surgery planning in amblyopic patients--which eye first? Awareness of the potential for post-operative diplopia amongst consultant ophthalmic surgeons in Wales.

Authors:  Gwyn Samuel Williams; Mahmoud Radwan; Jay Menon
Journal:  Ulster Med J       Date:  2013-05

Review 7.  Diplopia as the Complication of Cataract Surgery.

Authors:  Maciej Gawęcki; Andrzej Grzybowski
Journal:  J Ophthalmol       Date:  2016-02-21       Impact factor: 1.909

8.  Does the addition of hyaluronidase improve the quality of peribulbar anesthesia in cataract surgery? - A randomized double blinded study.

Authors:  Nagarajan Swathi; K Srikanth; S Venipriya
Journal:  Saudi J Ophthalmol       Date:  2018-03-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.